Crossref
Regarding plasma-derived von Willebrand factor concentrates: what about viral safety?
Revista Hemostasia y Trombosis · 30.10.2026 · 3 (2)
DOI: 10.24875/rht.m26000097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Hemostasia y Trombosis, online erschienen am 30.10.2026. Verfasst von Manuel Rodríguez-López und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Rodríguez-López, M., & Núñez-Vázquez, R. J. (2026). Regarding plasma-derived von Willebrand factor concentrates: what about viral safety?. Revista Hemostasia y Trombosis, 3(2). https://doi.org/10.24875/rht.m26000097
Vancouver
Rodríguez-López M, Núñez-Vázquez RJ. Regarding plasma-derived von Willebrand factor concentrates: what about viral safety?. Revista Hemostasia y Trombosis. 2026;3(2). doi:10.24875/rht.m26000097
BibTeX
@article{RodrguezLpez2026,
author = {Rodríguez-López, Manuel and Núñez-Vázquez, Ramiro J.},
title = {Regarding plasma-derived von Willebrand factor concentrates: what about viral safety?},
journal = {Revista Hemostasia y Trombosis},
year = {2026},
volume = {3},
number = {2},
doi = {10.24875/rht.m26000097}
}
EUVIMED